Related Experiment Video
Updated: Dec 27, 2025

Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry
Published on: June 9, 2019
Metabolic features of cancer cells in NRF2 addiction status
Keito Okazaki1, Thales Papagiannakopoulos2, Hozumi Motohashi3
1Department of Gene Expression Regulation, Institute of Development, Aging and Cancer, Tohoku University, Sendai, 980-8575, Japan.
Abstract:
The KEAP1-NRF2 system is a sulfur-employing defense mechanism against oxidative and electrophilic stress. NRF2 is a potent transcription activator for genes mediating sulfur-involving redox reactions, and KEAP1 controls the NRF2 activity in response to the stimuli by utilizing reactivity of sulfur atoms. In many human cancer cells, the KEAP1-mediated regulation of NRF2 activity is abrogated, resulting in the persistent activation of NRF2. Persistently activated NRF2 drives malignant progression of cancers by increasing therapeutic resistance and promoting aggressive tumorigenesis, a state termed as NRF2 addiction. In NRF2-addicted cancer cell, NRF2 contributes to metabolic reprogramming in cooperation with other oncogenic pathways. In particular, NRF2 strongly activates cystine uptake coupled with glutamate excretion and glutathione synthesis, which increases consumption of intracellular glutamate. Decreased availability of glutamate limits anaplerosis of the TCA cycle, resulting in low mitochondrial respiration, and nitrogen source, resulting in the high dependency on exogenous non-essential amino acids. The highly enhanced glutathione synthesis is also likely to alter sulfur metabolism, which can contribute to the maintenance of the mitochondrial membrane potential in normal cells. The potent antioxidant and detoxification capacity supported by abundant production of glutathione is achieved at the expense of central carbon metabolism and requires skewed metabolic flow of sulfur. These metabolic features of NRF2 addiction status provide clues for novel therapeutic strategies to target NRF2-addicted cancer cells.
Insights
The KEAP1-NRF2 system regulates cellular defense against stress. In cancers, this system
Area of Science:
- Cellular Biology
- Biochemistry
- Oncology
Background:
- The Kelch-like ECH-associated protein 1 (KEAP1)-Nuclear factor erythroid 2-related factor 2 (NRF2) pathway is crucial for cellular defense against oxidative and electrophilic stress.
- KEAP1 normally inhibits NRF2, a transcription factor that activates genes involved in redox reactions.
- Dysregulation of the KEAP1-NRF2 pathway leads to persistent NRF2 activation, a state known as NRF2 addiction in cancer cells.
Purpose of the Study:
- To investigate the metabolic consequences of NRF2 addiction in cancer cells.
- To elucidate how persistent NRF2 activation drives malignant progression and therapeutic resistance.
- To identify novel therapeutic strategies targeting NRF2-addicted cancers based on their metabolic vulnerabilities.
Main Methods:
- Analysis of gene expression patterns related to NRF2 targets.
- Metabolic flux analysis in cancer cells with varying NRF2 activity.
- Investigation of amino acid and glutathione metabolism.
- Assessment of TCA cycle anaplerosis and mitochondrial respiration.
Main Results:
- NRF2 addiction promotes metabolic reprogramming, including enhanced cystine uptake and glutathione synthesis.
- This leads to increased glutamate consumption, limiting TCA cycle anaplerosis and mitochondrial respiration.
- Cancer cells become dependent on exogenous non-essential amino acids.
- Altered sulfur metabolism supports antioxidant capacity at the expense of central carbon metabolism.
Conclusions:
- NRF2 addiction creates specific metabolic dependencies in cancer cells.
- Targeting these metabolic vulnerabilities offers a promising therapeutic strategy for NRF2-addicted cancers.
- Understanding the metabolic rewiring driven by NRF2 is key to developing effective cancer treatments.
More Related Videos
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Treatment Resistant Cancers
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Mitogens and the Cell Cycle

